Tirzepatide (Mounjaro) for Medical
Weight Loss in India
A plain-language educational guide to tirzepatide — what it is, how it works, its approved uses in India, who may be a candidate, and why it must be used under medical supervision. Medically reviewed by Dr. Manuj Sondhi, MRCP (UK), MD, DNB — Consultant Physician & Diabetologist, Nirvana Clinic, Greater Noida · Last updated: 10 July 2026Part of the complete GLP-1 Therapy Guide for India → This page is for information only; it is not advice, advertising, or an offer to supply any medicine.
Tirzepatide (Mounjaro) — How It Works
Tirzepatide is a once-weekly injectable medicine by Eli Lilly, known by the brand name Mounjaro. In India it is approved by the Central Drugs Standard Control Organisation (CDSCO) for type-2 diabetes and chronic weight management, and it has been available in India since 2025. This page is part of our complete GLP-1 therapy guide for India.
What makes tirzepatide distinctive is its dual-hormone mechanism. It activates both the GIP and GLP-1 receptors — two gut hormones involved in appetite, satiety, insulin sensitivity, and metabolism — whereas semaglutide acts on the GLP-1 receptor alone. Acting on two pathways can produce stronger appetite regulation.
In clinical trials (the SURMOUNT programme), tirzepatide produced substantial average weight reduction over the study period, and head-to-head data suggest a greater average effect than semaglutide. Individual results vary, and trial averages do not predict any one person's outcome.
An important point: approval does not mean the medicine is right for everyone. Whether tirzepatide is appropriate for a particular person — for weight loss, diabetes, or both — is a clinical decision that only a registered physician can make after individual assessment. Tirzepatide is prescription-only and must be used under medical supervision throughout treatment.
"GLP-1 and dual-receptor medicines have changed how we approach metabolic disease. But they are tools that work only when the patient is properly selected, the medicine is appropriate, dosing is careful, and progress is monitored — alongside nutrition and activity. They are not a shortcut, and they are not for everyone."— Dr. Manuj Sondhi, MRCP (UK), Consultant Physician & Diabetologist, Nirvana Clinic, Greater Noida
Semaglutide vs Tirzepatide — How They Differ
A factual comparison of the two molecules. This is general education, not a recommendation of one medicine over another; suitability is decided individually with a physician.
(Mounjaro)
(Ozempic / Wegovy)
Effects described qualitatively; trial averages vary between individuals. Both are prescription-only medicines requiring medical supervision. Read the fuller educational comparison: Semaglutide vs Tirzepatide →
Who May — and May Not — Be a Candidate
General guidance only. Whether tirzepatide is appropriate for a particular person can only be decided by a physician after individual assessment.
How Supervised Treatment Works at Nirvana Clinic
A medically supervised programme — not a prescribe-and-send-away service. Where treatment is appropriate, Dr. Manuj monitors progress at every step.
Full clinical evaluation — BMI, blood tests (HbA1c, kidney, liver, lipids, thyroid), medical history, and goals — to assess whether a medicine is appropriate at all.
Where indicated, treatment begins with detailed guidance on technique, a side-effect plan, and dietary and activity advice from day one.
The dose is increased gradually, as tolerated, with progress tracked through weight, labs, and review. Rushing is the main cause of intolerance.
A structured plan for treatment duration and, where appropriate, tapering — with lifestyle anchoring to support lasting results.
Consultant Physician & Diabetologist — Nirvana Clinic & Fortis Hospital, Greater Noida
An MRCP (UK)-qualified physician and diabetologist with 15+ years in metabolic medicine, Dr. Manuj has applied that experience to GLP-1 therapy since its India launch. His focus is the underlying metabolic picture behind obesity — not just the number on a scale — with a thorough, evidence-based approach to patient selection, dosing, and monitoring.
Tirzepatide in India — Frequently Asked Questions
QWhat is Mounjaro approved for in India?▼
Mounjaro (tirzepatide) is approved in India by CDSCO for type-2 diabetes and for chronic weight management. Whether it is appropriate for a particular person is an individual clinical decision made by a registered physician after assessment. It is a prescription-only medicine and must be used under medical supervision.
QHow is tirzepatide different from semaglutide?▼
Tirzepatide acts on two receptors (GIP and GLP-1), while semaglutide acts on the GLP-1 receptor alone. Clinical trials suggest tirzepatide produces greater average weight reduction, but the right choice for an individual depends on their clinical situation and is decided with a physician. Effects vary between people.
QWhat does tirzepatide cost in India?▼
Cost varies by brand, dose, formulation, pharmacy and over time, and is discussed only after medical assessment where treatment is clinically appropriate. For current pricing, ask your physician or a licensed pharmacy. This page does not provide drug prices.
QWhat are the side effects of tirzepatide?▼
The most common side effects are nausea, diarrhoea, constipation, vomiting and reduced appetite, particularly during dose increases; these are usually mild and improve with time. Rare but serious risks include pancreatitis and gallbladder problems — which is why medical supervision is essential.
QWill I regain weight after stopping?▼
Weight regain is possible if habits have not changed. Supervised care includes nutrition and activity support and a planned approach to treatment duration, so sustainable habits are built alongside any medical treatment.
QWho should not take tirzepatide?▼
It is not suitable for people with type-1 diabetes, a personal or family history of medullary thyroid carcinoma or MEN-2, a history of pancreatitis or severe gastrointestinal disease, or during pregnancy or planned conception. A physician assessment is essential.
QHow do I arrange a supervised assessment in Greater Noida?▼
Call or WhatsApp Dr. Manuj Sondhi at +91 8800262767. Nirvana Clinic, Shop GF-93, Sun Twilight Mall, opposite Delta 1 Metro Station, Greater Noida. A full consultation with blood tests is required before any treatment. Mon–Sat, 9 AM to 8 PM.
Medical Weight Loss — Greater Noida
Sun Twilight Mall
Opp. Delta 1 Metro Station
Greater Noida, UP 201308
9:00 AM – 8:00 PM
Sunday — Closed
Same-day appointments available
Last updated: 10 July 2026
Considering Medically Supervised Weight Loss?
Whether a medicine like tirzepatide is appropriate for you can only be decided after a proper evaluation.
Supervised assessment with Dr. Manuj Sondhi, MRCP (UK) · Same-day appointments Mon–Sat